Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on BOD Australia.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Cannabis play BOD to start clinical trial of CBD drug for COVID
Health & Biotech
Weed Week: Uber Eats enters Canada’s cannabis market and Montu breaks crowdfunding records
Health & Biotech
California just passed a bill to legalise hemp – and there are ASX cannabis stocks that could benefit
Health & Biotech
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops
Health & Biotech
ASX Health Stocks: Imugene granted Japan patent, share price is now up 50% in a month
Mining
ASX Pot Stocks: BOD Australia jumps 12% on record $7.52 million revenue for FY21
News
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
News
Last Orders: ASX begins FY22 down 0.65 per cent
News
Last Orders: ASX falls despite strong jobs data
News
Last Orders: ASX rockets over 1 per cent led by resources; hits record closing high
News
10 at 10: These ASX stocks have made their investors the most proud this morning
News
Quarterlies Top 5: Sequoia Financial takes the cake this morning
Health & Biotech
Canadian cannabis giants Aphria and Tilray closer to merger; ASX cannabis stock Bod snares new CFO
Health & Biotech
1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help
Health & Biotech
Weed Week: US pot legalisation picks up steam, and the Big Apple could be next
News
